Alkermes plc Ireland


Date range: 1 April 2021 - 31 March 2022

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Alkermes plc published between 1 April 2021 - 31 March 2022 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Article Count and Share for Alkermes plc
Count Share
1 0.04

Outputs by subject (Share)

Outputs by subject
Subject Count Share
1 0.04

Share output for the past 5 years

Share per year
2016 2017 2018 2019 2020
0.00 0.00 0.71 0.06 0.00

Compare Alkermes plc with other institutions


Date range: 1 April 2021 - 31 March 2022

International vs. domestic collaboration by Share

  • 0.00% Domestic
  • 100.00% International

Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators with Alkermes plc by Share (0 total)

Top 10 international collaborators with Alkermes plc by Share (9 total)

  1. Alkermes plc and Entasis Therapeutics (0.62)
    Alkermes plc0.04
    Entasis Therapeutics0.58
  2. Alkermes plc and Colorado State University (0.12)
    Alkermes plc0.04
    Colorado State University0.08
  3. Alkermes plc and University of Florida (UF) (0.12)
    Alkermes plc0.04
    University of Florida (UF)0.08
  4. Alkermes plc and UCB S.A. (0.12)
    Alkermes plc0.04
    UCB S.A.0.08
  5. Alkermes plc and Novartis International AG (0.10)
    Alkermes plc0.04
    Novartis International AG0.06
  6. Alkermes plc and Takeda Pharmaceutical Company Limited (0.08)
    Alkermes plc0.04
    Takeda Pharmaceutical Company Limited0.04
  7. Alkermes plc and Johnson & Johnson (0.06)
    Alkermes plc0.04
    Johnson & Johnson0.02
  8. Alkermes plc and Pfizer Inc. (0.06)
    Alkermes plc0.04
    Pfizer Inc.0.02
  9. Alkermes plc and Merck KGaA (0.06)
    Alkermes plc0.04
    Merck KGaA0.02